PF
Privium Fund Management B.V.
13F filer · CIK 0001795097Reported Aug 7, 2026
Net seller this quarter
13F portfolio value$544MU.S. long equity reported on 13F
Positions6110 new · 8 closed
Net flow last quarter-$16.8MBuys minus sells
Top 10 positions weight61.8%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 7, 202661 positions | |||||
| $95.9M | 17.62% | 0.01% | +2.7% | Q2 2022 | |
| $42.2M | 7.76% | 0.09% | -9.1% | Q4 2021 | |
| $36M | 6.62% | 0.00% | Not reported | Q3 2022 | |
| $33.4M | 6.13% | 0.00% | +12.0% | Q3 2022 | |
| $25.4M | 4.66% | 0.19% | +10.3% | Q4 2021 | |
| $25.3M | 4.64% | 0.03% | -17.9% | Q4 2021 | |
| $23.3M | 4.29% | 0.01% | Not reported | Q4 2021 | |
| $19.1M | 3.51% | 0.17% | -36.2% | Q4 2021 | |
| $18.2M | 3.35% | 0.41% | New | Q2 2026 | |
| $17.6M | 3.23% | 0.35% | +5.9% | Q1 2023 | |
| $16.2M | 2.98% | 0.00% | Not reported | Q2 2022 | |
| $15.6M | 2.86% | 0.10% | +6.3% | Q3 2025 | |
| $15.1M | 2.78% | 0.47% | -32.5% | Q4 2021 | |
| $13.4M | 2.46% | Not reported | New | Q2 2026 | |
| $12.9M | 2.37% | Not reported | Not reported | Q3 2024 | |
| $11.3M | 2.08% | 0.34% | -7.1% | Q4 2021 | |
| $10.5M | 1.92% | 0.32% | +24.4% | Q4 2024 | |
| $10.5M | 1.92% | 0.03% | +10.5% | Q1 2022 | |
| $10.3M | 1.89% | 5.24% | +1.0% | Q4 2021 | |
| $9.78M | 1.80% | 0.08% | -32.0% | Q1 2023 | |
| $7.73M | 1.42% | 0.43% | -11.8% | Q4 2024 | |
| $6.83M | 1.26% | Not reported | New | Q2 2026 | |
| $5.91M | 1.09% | 0.14% | -9.8% | Q1 2026 | |
| $4.67M | 0.86% | 0.00% | -17.2% | Q4 2021 | |
| $4.29M | 0.79% | 0.04% | -18.8% | Q1 2026 | |
| $4.15M | 0.76% | 0.04% | Not reported | Q1 2022 | |
| $3.42M | 0.63% | 0.01% | -7.0% | Q4 2021 | |
| $3.19M | 0.59% | 0.15% | Not reported | Q4 2025 | |
| $2.8M | 0.51% | 0.01% | +11.5% | Q2 2025 | |
| $2.77M | 0.51% | Not reported | +100.0% | Q2 2025 | |
| $2.65M | 0.49% | 0.21% | -7.5% | Q1 2024 | |
| $2.52M | 0.46% | 0.01% | -15.4% | Q1 2022 | |
| $2.45M | 0.45% | 0.13% | +196.7% | Q2 2025 | |
| $2.45M | 0.45% | 0.05% | +4.9% | Q1 2022 | |
| $2.41M | 0.44% | 0.07% | +9.9% | Q3 2025 | |
| $2.32M | 0.43% | 0.01% | -7.6% | Q4 2021 | |
| $2.1M | 0.39% | 0.01% | Not reported | Q1 2022 | |
| $1.58M | 0.29% | 0.50% | -15.3% | Q4 2025 | |
| $1.5M | 0.27% | 0.02% | New | Q2 2026 | |
| $1.4M | 0.26% | 0.12% | Not reported | Q3 2024 | |
| $1.35M | 0.25% | 0.06% | +9.4% | Q2 2024 | |
| $1.24M | 0.23% | 0.00% | New | Q2 2026 | |
| $1.2M | 0.22% | 0.16% | -47.1% | Q3 2023 | |
| $1.12M | 0.21% | 0.36% | Not reported | Q3 2024 | |
| $1.02M | 0.19% | 0.01% | New | Q2 2026 | |
| $835K | 0.15% | 0.22% | +0.8% | Q2 2022 | |
| $780K | 0.14% | 0.01% | Not reported | Q4 2021 | |
| $730K | 0.13% | 0.01% | +102.2% | Q4 2021 | |
| $729K | 0.13% | 0.00% | New | Q2 2026 | |
| $722K | 0.13% | 0.20% | -24.4% | Q4 2024 | |
| Q1 2026Reported May 5, 202659 positions | |||||
| $82.5M | 17.18% | 0.01% | -2.8% | Q2 2022 | |
| $48.3M | 10.05% | 0.10% | -0.7% | Q4 2021 | |
| $32.5M | 6.76% | 0.03% | -1.5% | Q4 2021 | |
| $29.3M | 6.09% | 0.01% | Not reported | Q4 2021 | |
| $26M | 5.42% | 0.00% | +3.3% | Q3 2022 | |
| $23M | 4.79% | 0.26% | -7.9% | Q4 2021 | |
| $21.8M | 4.53% | 0.17% | +20.4% | Q4 2021 | |
| $16M | 3.33% | 0.33% | +2.8% | Q1 2023 | |
| $14.1M | 2.94% | 0.00% | Not reported | Q2 2022 | |
| $13.8M | 2.87% | 0.03% | Not reported | Q4 2021 | |
| $12.6M | 2.63% | 0.00% | +3.3% | Q3 2022 | |
| $12M | 2.50% | Not reported | Not reported | Q3 2024 | |
| $11.4M | 2.38% | 0.08% | Not reported | Q4 2021 | |
| $11M | 2.28% | 0.10% | +14.3% | Q3 2025 | |
| $9.93M | 2.07% | 0.11% | +3.3% | Q1 2023 | |
| ETESPREsperion Therapeutics, Inc. | $9.04M | 1.88% | 1.28% | New | Q1 2026 |
| $8.86M | 1.84% | 5.19% | +2.0% | Q4 2021 | |
| $8.03M | 1.67% | 0.03% | -40.4% | Q1 2022 | |
| $7.95M | 1.66% | 0.77% | +16.9% | Q4 2021 | |
| $7.64M | 1.59% | 0.37% | +2.0% | Q4 2021 | |
| $7.56M | 1.57% | 0.26% | +4.9% | Q4 2024 | |
| $5.21M | 1.09% | 0.05% | New | Q1 2026 | |
| $5.07M | 1.06% | 0.00% | +21.4% | Q4 2021 | |
| $4.89M | 1.02% | 0.16% | New | Q1 2026 | |
| $4.28M | 0.89% | 0.49% | +11.0% | Q4 2024 | |
| $4.04M | 0.84% | 0.01% | Not reported | Q4 2021 | |
| $3.39M | 0.71% | 0.17% | Not reported | Q4 2025 | |
| $2.89M | 0.60% | 0.04% | -8.2% | Q1 2022 | |
| $2.77M | 0.58% | 0.01% | -10.8% | Q1 2022 | |
| $2.49M | 0.52% | 0.01% | Not reported | Q4 2021 | |
| $2.4M | 0.50% | 0.01% | -18.9% | Q2 2025 | |
| $2.4M | 0.50% | 0.53% | Not reported | Q4 2025 | |
| $2.04M | 0.42% | 0.04% | Not reported | Q1 2022 | |
| $1.84M | 0.38% | 0.26% | +6.1% | Q1 2024 | |
| $1.75M | 0.36% | 0.13% | +24.9% | Q3 2024 | |
| $1.63M | 0.34% | 0.08% | -9.1% | Q4 2025 | |
| $1.59M | 0.33% | 0.33% | -18.9% | Q3 2023 | |
| $1.52M | 0.32% | 0.06% | -10.5% | Q3 2025 | |
| $1.52M | 0.32% | 0.01% | -39.5% | Q1 2022 | |
| $1.48M | 0.31% | 0.00% | +39.6% | Q1 2023 | |
| $1.18M | 0.24% | 0.28% | +6.5% | Q4 2024 | |
| $1.1M | 0.23% | 0.63% | +3.8% | Q4 2025 | |
| $1.09M | 0.23% | 0.02% | New | Q1 2026 | |
| $1M | 0.21% | 0.04% | +7.0% | Q2 2025 | |
| $948K | 0.20% | 0.00% | -52.5% | Q4 2021 | |
| $867K | 0.18% | 0.22% | +42.3% | Q2 2022 | |
| $830K | 0.17% | Not reported | Not reported | Q2 2025 | |
| $813K | 0.17% | 0.06% | +10.3% | Q2 2024 | |
| $791K | 0.16% | 0.01% | -20.9% | Q4 2021 | |
| $707K | 0.15% | 0.01% | -23.6% | Q3 2025 | |
| Q4 2025Reported Feb 3, 202656 positions | |||||
| $103M | 18.92% | 0.01% | -6.4% | Q2 2022 | |
| $66M | 12.15% | 0.10% | -1.2% | Q4 2021 | |
| $39.5M | 7.27% | 0.03% | -28.4% | Q4 2021 | |
| $35.6M | 6.55% | 0.01% | Not reported | Q4 2021 | |
| $27.9M | 5.14% | 0.00% | -18.8% | Q3 2022 | |
| $26.4M | 4.87% | 0.29% | -16.0% | Q4 2021 | |
| $19.1M | 3.51% | 0.15% | -3.2% | Q4 2021 | |
| $17.9M | 3.29% | 0.03% | Not reported | Q4 2021 | |
| $17.7M | 3.25% | 0.33% | +71.2% | Q1 2023 | |
| $17.6M | 3.24% | 0.08% | -13.8% | Q4 2021 | |
| $15.1M | 2.78% | 0.00% | Not reported | Q2 2022 | |
| $12.9M | 2.38% | 0.05% | +41.5% | Q1 2022 | |
| $12.8M | 2.37% | 0.00% | Not reported | Q3 2022 | |
| $10.8M | 1.99% | 5.09% | +7.2% | Q4 2021 | |
| $10.6M | 1.95% | 0.10% | +115.4% | Q3 2025 | |
| $10.5M | 1.94% | Not reported | +31.8% | Q3 2024 | |
| $10.4M | 1.91% | 0.11% | +7.9% | Q1 2023 | |
| $9.96M | 1.83% | 0.67% | +7.8% | Q4 2021 | |
| $8.89M | 1.64% | 0.25% | Not reported | Q4 2024 | |
| $8.22M | 1.51% | 0.37% | +23.4% | Q4 2021 | |
| $5.4M | 0.99% | 0.17% | New | Q4 2025 | |
| $5.03M | 0.93% | 0.44% | +9.2% | Q4 2024 | |
| $4.24M | 0.78% | 0.00% | +12.7% | Q4 2021 | |
| $3.85M | 0.71% | 0.00% | -43.2% | Q4 2021 | |
| $3.28M | 0.60% | 0.10% | +13.5% | Q3 2024 | |
| $3.18M | 0.59% | 0.53% | New | Q4 2025 | |
| $3.17M | 0.58% | 0.01% | +75.3% | Q2 2025 | |
| $3M | 0.55% | 0.04% | Not reported | Q1 2022 | |
| $2.63M | 0.48% | 0.01% | +18.5% | Q1 2022 | |
| $2.33M | 0.43% | 0.01% | Not reported | Q4 2021 | |
| $2.25M | 0.41% | 0.04% | +7.2% | Q1 2022 | |
| $1.98M | 0.36% | 0.07% | +17.2% | Q3 2025 | |
| $1.91M | 0.35% | 0.26% | +0.1% | Q4 2024 | |
| $1.75M | 0.32% | 0.09% | New | Q4 2025 | |
| $1.59M | 0.29% | 0.25% | +22.7% | Q1 2024 | |
| $1.58M | 0.29% | 0.36% | +6.4% | Q3 2023 | |
| $1.49M | 0.27% | 0.00% | +97.0% | Q4 2021 | |
| $1.46M | 0.27% | 0.01% | +5.5% | Q1 2022 | |
| $1.3M | 0.24% | Not reported | Not reported | Q2 2025 | |
| $1.24M | 0.23% | 0.66% | New | Q4 2025 | |
| $1.12M | 0.21% | 0.07% | Not reported | Q3 2024 | |
| $940K | 0.17% | 0.00% | Not reported | Q1 2023 | |
| $925K | 0.17% | 0.04% | Not reported | Q2 2025 | |
| $907K | 0.17% | 0.06% | +22.2% | Q2 2024 | |
| $830K | 0.15% | 0.01% | -16.8% | Q4 2021 | |
| $703K | 0.13% | 0.03% | -51.0% | Q3 2022 | |
| $649K | 0.12% | 0.12% | +5.6% | Q1 2022 | |
| $597K | 0.11% | 0.16% | -60.7% | Q2 2022 | |
| $577K | 0.11% | 0.01% | +36.9% | Q3 2025 | |
| $560K | 0.10% | 0.11% | -23.0% | Q2 2024 | |
| Q3 2025Reported Nov 4, 202558 positions | |||||
| $109M | 19.51% | 0.01% | +0.8% | Q2 2022 | |
| $66.3M | 11.92% | 0.05% | -16.7% | Q4 2021 | |
| $61.7M | 11.09% | 0.11% | -3.5% | Q4 2021 | |
| $36.5M | 6.56% | 0.01% | -42.9% | Q4 2021 | |
| $32.7M | 5.88% | 0.00% | Not reported | Q3 2022 | |
| $28.6M | 5.14% | 0.09% | -23.8% | Q4 2021 | |
| $26.7M | 4.79% | 0.03% | +12.9% | Q4 2021 | |
| $22.5M | 4.05% | 0.62% | -13.7% | Q4 2021 | |
| $16.3M | 2.94% | 0.35% | -22.6% | Q4 2021 | |
| $16.3M | 2.93% | 0.15% | -7.0% | Q4 2021 | |
| $15.1M | 2.72% | 0.00% | Not reported | Q2 2022 | |
| $10.6M | 1.91% | 4.75% | 0.0% | Q4 2021 | |
| $9.71M | 1.75% | 0.00% | Not reported | Q3 2022 | |
| $8.72M | 1.57% | 0.30% | +14.4% | Q4 2021 | |
| $7.76M | 1.40% | 0.19% | Not reported | Q1 2023 | |
| $7.27M | 1.31% | 0.04% | +153.3% | Q1 2022 | |
| $6.4M | 1.15% | 0.10% | Not reported | Q1 2023 | |
| $6.1M | 1.10% | Not reported | New | Q3 2025 | |
| $5.77M | 1.04% | 0.25% | -11.2% | Q4 2024 | |
| $5.4M | 0.97% | 0.00% | +9.0% | Q4 2021 | |
| $5.4M | 0.97% | Not reported | Not reported | Q3 2024 | |
| $4.48M | 0.81% | 0.01% | Not reported | Q4 2021 | |
| $3.92M | 0.71% | 0.42% | +82.7% | Q4 2024 | |
| $3.25M | 0.58% | 0.00% | Not reported | Q4 2021 | |
| $2.59M | 0.47% | 0.04% | -10.5% | Q1 2022 | |
| $2.58M | 0.46% | 0.05% | New | Q3 2025 | |
| ABRNAMAvidity Biosciences, Inc. | $2.31M | 0.42% | 0.04% | +15.2% | Q1 2024 |
| $2.27M | 0.41% | Not reported | +81.8% | Q2 2025 | |
| $2.15M | 0.39% | 0.04% | +30.6% | Q1 2022 | |
| $2M | 0.36% | 0.01% | +12.7% | Q1 2022 | |
| $1.92M | 0.35% | 0.02% | Not reported | Q4 2023 | |
| $1.87M | 0.34% | 0.01% | +72.9% | Q2 2025 | |
| $1.72M | 0.31% | 0.42% | Not reported | Q3 2023 | |
| $1.5M | 0.27% | 0.04% | -52.6% | Q1 2024 | |
| $1.48M | 0.27% | 0.06% | New | Q3 2025 | |
| $1.41M | 0.25% | 0.40% | Not reported | Q2 2022 | |
| $1.34M | 0.24% | 0.20% | Not reported | Q1 2024 | |
| $1.28M | 0.23% | 0.35% | +7.9% | Q4 2024 | |
| $1.24M | 0.22% | 0.11% | +25.4% | Q3 2024 | |
| $1.21M | 0.22% | 0.01% | -54.6% | Q1 2022 | |
| $1.17M | 0.21% | 0.05% | +10.0% | Q3 2022 | |
| $962K | 0.17% | 0.00% | +2.0% | Q1 2023 | |
| $932K | 0.17% | 0.95% | Not reported | Q2 2024 | |
| $884K | 0.16% | 0.07% | -18.4% | Q3 2024 | |
| $846K | 0.15% | 0.02% | Not reported | Q4 2021 | |
| $718K | 0.13% | 0.01% | -37.7% | Q3 2022 | |
| $677K | 0.12% | 0.00% | Not reported | Q4 2021 | |
| $581K | 0.10% | 0.02% | Not reported | Q2 2024 | |
| $568K | 0.10% | 0.14% | +36.1% | Q2 2024 | |
| $503K | 0.09% | 0.12% | +5.0% | Q1 2022 | |
Premium opens every quarter this fund has filed